MoonLake Immunotherapeutics

MLTXNASDAQ · USD
11.80USD-0.24 (-2.00%)
122

MoonLake Immunotherapeutics (MLTX) Covered Calls

As of September 25, 2026, MLTX has 46 covered call opportunities in the coming three months. Return ranges from 9.6 to 319.4% until expiration. Annualized return ranges from 19.2 to 434.5%. The nearest expiration is October 16, 2026. Maximum potential profit is $3,846.

Read more

Running MLTX covered calls helps you generate consistent income from MoonLake Immunotherapeutics's shares you already own, turning a long stock position into a yield-producing asset. A covered call on MoonLake Immunotherapeutics involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best MLTX covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if MLTX stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling MLTX covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given MoonLake Immunotherapeutics covered call is worth writing.

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.

Income-focused investors, long-term MLTX holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling MLTX covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best MoonLake Immunotherapeutics covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile56.75% Neutral
  • Market cap (M$)1,025
  • 52 weeks high-80.81%
  • 52 weeks low102.35%
  • Analyst recommendationBuy
    1.80
  • Target price$30.38
    157.46% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-04
  • P/E—
  • Future P/E—
  • EPS (ttm)-3.84
  • EPS growth next 5 years9.01%

As of September 25, 2026

2026-10-162115.0024.580.050.15301.0025.00434.52-0.42+0.114620.10
2026-11-205620.0066.110.050.30801.0066.53433.62-0.42+0.104730.25
2026-11-205618.0049.500.100.45606.0050.33328.06-0.83+0.151360.35
2026-10-162114.0016.280.100.25206.0017.11297.38-0.83+0.194020.15
2027-01-1511222.5086.880.253.301071.0088.95289.89-2.08+0.38223.05
2027-02-1914725.00107.640.250.701321.00109.72272.43-2.08+0.171130.45
2027-01-1511221.0074.420.350.90931.0077.33252.00-2.91+0.225840.55
2028-01-2148350.00315.280.505.003846.00319.44241.40-4.15+0.42584.50
2027-01-1511220.0066.110.400.60836.0069.44226.28-3.32+0.201,1810.20
2028-01-2148345.00273.750.051.803301.00274.17207.19-0.42+0.21401.75

As of September 25, 2026

Sell covered calls with the data behind you

Find the best MLTX covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial